CorneaGen Inc. — Form D
CorneaGen Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-19. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-04-19
- Form: D
- Accession: 0001687524-18-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 1
- Date of first sale: 2018-04-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-310594
Issuer
- Name: CorneaGen Inc.
- CIK: 0001687524
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1200 6TH AVENUE, SUITE 300, SEATTLE, WA, 98101
- Phone: (206) 682-8500
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Richard Lindstrom | Director | Avon by the Sea, NJ |
| William Link | Director | Corona Del Mar, CA |
| Tim McLaughlin | Executive Officer | Arlington, VA |
| Monty Montoya | Director | Needham, MA |
| Monty Montoya | Executive Officer | Needham, MA |
| KUSH PARIKH | Director | SEATTLE, WA |
| GRETCHEN COKER | Executive Officer | SEATTLE, WA |
| HOWARD MENDELSOHN | Executive Officer | SEATTLE, WA |
| BOB STEVENS | Executive Officer | SEATTLE, WA |
| BERNIE ILIAKIS | Executive Officer | SEATTLE, WA |
| MELODY SUMMERS | Director | SEATTLE, WA |
Other filings by this issuer (2)
More